PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About

Mature T-Cell & NK-Cell Neoplasms

T/NK-Cell Lymphomas

  • Anaplastic Large Cell Lymphoma, ALK+ (ALCL, ALK+)
  • Anaplastic Large Cell Lymphoma, ALK- (ALCL, ALK-)
  • Angioimmunoblastic T-Cell Lymphoma (AILT)
  • Extranodal NK/T-Cell Lymphoma, Nasal Type
  • Adult T-Cell Leukemia/Lymphoma
  • EBV+ T-Cell Lymphoproliferative Diseases of Childhood
  • Enteropathy-Associated T-Cell Lymphoma
  • Hepatosplenic T-Cell Lymphoma
  • Peripheral T-Cell Lymphoma, NOS

T/NK-Cell Leukemias

  • T-Cell Large Granular Lymphocytic Leukemia (T-LGL)
  • T-Cell Prolymphocytic Leukemia (T-PLL)
  • Aggressive NK-Cell Leukemia
  • Chronic Lymphoproliferative Disorder of NK Cells
  • Sezary Syndrome

Skin

  • Mycosis Fungoides
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma
  • Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders
  • Primary Cutaneous Peripheral T-Cell Lymphomas, Rare Subtypes
References

Swerdlow SH, Campo E, Harris, NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds):  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon 2017

Share this:

  • Share on X (Opens in new window) X
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Share on LinkedIn (Opens in new window) LinkedIn

PathMD E-Mail Signup

Poll

What is your most commonly used breast specific IHC marker?
Results

Check-out more in-depth information on these markers the PathMD IHC section of our website/app.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress